11-47586779-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001164379.3(FAM180B):c.11C>A(p.Thr4Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000651 in 1,536,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/16 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001164379.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM180B | NM_001164379.3 | c.11C>A | p.Thr4Asn | missense_variant | Exon 1 of 3 | ENST00000538490.3 | NP_001157851.1 | |
FAM180B | NM_001367966.1 | c.11C>A | p.Thr4Asn | missense_variant | Exon 1 of 2 | NP_001354895.1 | ||
FAM180B | NM_001367967.1 | c.-69C>A | 5_prime_UTR_variant | Exon 1 of 2 | NP_001354896.1 | |||
FAM180B | NM_001367968.1 | c.-211C>A | 5_prime_UTR_variant | Exon 1 of 3 | NP_001354897.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000140 AC: 2AN: 143314Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 76614
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1384788Hom.: 0 Cov.: 31 AF XY: 0.00000293 AC XY: 2AN XY: 683346
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.11C>A (p.T4N) alteration is located in exon 1 (coding exon 1) of the FAM180B gene. This alteration results from a C to A substitution at nucleotide position 11, causing the threonine (T) at amino acid position 4 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at